SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-003946
Filing Date
2019-06-28
Accepted
2019-06-28 17:10:24
Documents
88
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-K a2239140z10-k.htm 10-K 1641170
2 EX-4.3 a2239140zex-4_3.htm EX-4.3 29740
3 EX-10.10 a2239140zex-10_10.htm EX-10.10 98298
4 EX-23.1 a2239140zex-23_1.htm EX-23.1 2617
5 EX-31.1 a2239140zex-31_1.htm EX-31.1 7291
6 EX-31.2 a2239140zex-31_2.htm EX-31.2 7276
7 EX-32.1 a2239140zex-32_1.htm EX-32.1 4955
8 EX-32.2 a2239140zex-32_2.htm EX-32.2 4706
  Complete submission text file 0001047469-19-003946.txt   8418249

Data Files

Seq Description Document Type Size
9 EX-101.INS repl-20190331.xml EX-101.INS 1944666
10 EX-101.SCH repl-20190331.xsd EX-101.SCH 64799
11 EX-101.CAL repl-20190331_cal.xml EX-101.CAL 55193
12 EX-101.DEF repl-20190331_def.xml EX-101.DEF 227242
13 EX-101.LAB repl-20190331_lab.xml EX-101.LAB 592546
14 EX-101.PRE repl-20190331_pre.xml EX-101.PRE 440883
Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-38596 | Film No.: 19930347
SIC: 2836 Biological Products, (No Diagnostic Substances)